Avillion Has Faith In Merck's Ablynx-Rejected Psoriasis Drug

 
• By Lucie Ellis-Taitt
SC1703_Chalkboard Strategy_1200x675
Is Merck's Deal With Avillion A Strategic Portfolio Decision Or Is The Company Distancing Itself From Potential Failure? • Source: Shutterstock

More from Deals

More from Business